Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| ZIOPHARM Oncology, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| ZIOPHARM Oncology, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| ZIOPHARM Oncology, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| ZIOPHARM Oncology, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| ZIOPHARM Oncology, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 9 | 1 |
| ZIOPHARM Oncology, Inc., Pharmaceuticals &Healthcare, Deal Details | 10 | 22 |
| Partnerships | 10 | 1 |
| Intrexon Enters into Co-Development Agreement with Ziopharm Oncology | 10 | 1 |
| Ziopharm Expands Co-Development Agreement with Intrexon | 11 | 1 |
| Mesoblast Enters Into Co-Development Agreement With Intrexon And Ziopharm Oncology | 12 | 2 |
| Ziopharm Oncology Plans To Enter Into Co-Marketing Agreement For Palifosfamide | 14 | 1 |
| ZIOPHARM Oncology Enters Into Co-Development Agreement With Intrexon | 15 | 2 |
| Licensing Agreements | 17 | 1 |
| Intrexon, Ziopharm Oncology Enter into Licensing Agreement with University of Texas MD Anderson Cancer Center | 17 | 2 |
| Ziopharm Amends Licensing Agreement with Solasia Pharma for Darinaparsin | 19 | 2 |
| ZIOPHARM Oncology Enters Into Licensing Agreement With Solasia Pharma For Darinaparsin | 21 | 2 |
| Equity Offering | 23 | 1 |
| Ziopharm Oncology Completes Exercise of Over-Allotment Option of Public Offering of Shares for USD100.6 Million | 23 | 2 |
| Ziopharm Oncology Completes Public Offering Of Shares For US$50 Million | 25 | 1 |
| ZIOPHARM Oncology Completes Public Offering Of Common Stock For US$50 Million | 26 | 2 |
| ZIOPHARM Oncology Completes An Underwritten Public Offering Of US$63.5 Million | 28 | 2 |
| ZIOPHARM Oncology Completes Underwritten Public Offering For US$35 Million | 30 | 2 |
| ZIOPHARM Oncology, Inc. - Key Competitors | 32 | 1 |
| Key Employees | 33 | 1 |
| Locations And Subsidiaries | 34 | 1 |
| Head Office | 34 | 1 |
| Appendix | 35 | 1 |
| Methodology | 35 | 1 |
| About GlobalData | 35 | 1 |
| Contact Us | 35 | 1 |
| Disclaimer | 35 | 1 |